#EADV
LightNews LightNews
collapseaphorisms.bsky.social
For the sufficiently interested

www.hcplive.com/view/climate...
Climate Change Tied to Skin Disease Worsening in 42% of Countries | HCPLive
The international SkinObservatory study found climate-related skin disease disproportionately affecting low-income nations at EADV 2026.
www.hcplive.com
September 30, 2026 at 12:35 PM
newsen.bsky.social
AbbVie Presents Promising Phase 2 Results for Zumilokibart at EADV 2026 as a Late Breaker#United_States#AbbVie#North_Chicago#Zumilokibart#EADV
AbbVie Presents Promising Phase 2 Results for Zumilokibart at EADV 2026 as a Late Breaker
At the EADV 2026 Congress, AbbVie shared encouraging Phase 2 data on Zumilokibart, showing significant improvements in atopic dermatitis treatment.
third-news.com
September 30, 2026 at 5:37 AM
newsen.bsky.social
Revolutionary Findings on Atopic Dermatitis Treatment Unveiled at EADV 2026#United_States#San_Francisco#Atopic_Dermatitis#Nektar_Therapeutics#Rezpegaldesleukin
Revolutionary Findings on Atopic Dermatitis Treatment Unveiled at EADV 2026
Nektar Therapeutics shares groundbreaking data at EADV Congress 2026, revealing early molecular responses to rezpegaldesleukin in treating atopic dermatitis.
third-news.com
September 30, 2026 at 2:40 PM
newsen.bsky.social
AbbVie Presents Groundbreaking Dermatology Research Results at 2026 EADV Congress#United_States#dermatology#AbbVie#North_Chicago#EADV2026
AbbVie Presents Groundbreaking Dermatology Research Results at 2026 EADV Congress
AbbVie shares innovative research on immune-mediated skin diseases during the 2026 EADV Congress, featuring advancements across multiple conditions and treatments.
third-news.com
September 30, 2026 at 5:06 AM
wisepress.bsky.social
Vienna is calling! 🇦🇹 We’re excited to be attending the EADV Congress 2026, bringing our Wisepress Book Stand to the event from 30 September – 3 October.

Come and browse our latest medical titles and find your next essential reference. 📖

See you at EADV 2026! 👋

#EADV2026 #EADV
September 30, 2026 at 7:00 AM
newsen.bsky.social
Q32 Bio Unveils Promising Results of Bempikibart for Alopecia Areata at EADV 2026#USA#Waltham#Q32_Bio#Bempikibart#Alopecia_Areata
Q32 Bio Unveils Promising Results of Bempikibart for Alopecia Areata at EADV 2026
At the EADV Congress 2026, Q32 Bio shared significant results from the SIGNAL-AA trial, highlighting the efficacy and safety of bempikibart for alopecia areata.
third-news.com
September 30, 2026 at 1:43 PM
newsen.bsky.social
Breakthrough Data from EADV 2026 Reveals Insight into DecisionDx-Melanoma and Surgical Management Benefits#United_States#Friendswood#Castle_Biosciences#DecisionDx-Melanoma#EADV_2026
Breakthrough Data from EADV 2026 Reveals Insight into DecisionDx-Melanoma and Surgical Management Benefits
Castle Biosciences has unveiled crucial data on DecisionDx-Melanoma at EADV 2026, indicating significant results for surgical decision-making and patient management.
third-news.com
September 30, 2026 at 8:40 PM
merlintrader.bsky.social
What Could EADV 2026 Change for $NKTR, $ATTO, $INCY and $ARQT in Dermatology?

https://www.merlintrader.com/nktr-atto-incy-arqt-dermatology-eadv-2026/
$NKTR $ATTO $INCY $ARQT: Dermatology’s Next Test
Dermatology at EADV: $NKTR, $ATTO, $INCY and $ARQT compared through durability, itch, topical access, clinical evidence and financing.
www.merlintrader.com
September 29, 2026 at 9:50 AM
newsen.bsky.social
Uriage Unveils Breakthrough Research on Triple Barrier Science at EADV 2026 in Vienna#Vienna#Austria#dermatology#EADV#Uriage
Uriage Unveils Breakthrough Research on Triple Barrier Science at EADV 2026 in Vienna
Discover Uriage's latest advancements in dermatological science, focusing on microbiome balance and innovative skin barrier technologies presented at EADV 2026.
third-news.com
October 1, 2026 at 7:22 PM
prismmarketview.bsky.social
Kenvue (#$KVUE) presents 12 new data sets across Neutrogena, Aveeno, and Regaine at EADV 2026, covering sunscreen benefits, skin-barrier care, and hair regrowth. No sales or earnings impact quantified.

prismmarketview.com/kenvue-highl...
Kenvue Highlights New Neutrogena, Aveeno and Regaine Research at EADV 2026
Key Points Kenvue’s brands will present 12 new scientific data sets at EADV 2026, covering sunscreen, skin-barrier care and hair regrowth. Neutrogena
prismmarketview.com
September 30, 2026 at 2:21 PM
newsen.bsky.social
Nektar Therapeutics to Unveil Key Findings on Rezpegaldesleukin at EADV Congress 2026#United_States#San_Francisco#Nektar_Therapeutics#Rezpegaldesleukin#EADV_Congress
Nektar Therapeutics to Unveil Key Findings on Rezpegaldesleukin at EADV Congress 2026
At the upcoming EADV Congress, Nektar Therapeutics will present significant findings on rezpegaldesleukin's efficacy for atopic dermatitis and alopecia areata.
third-news.com
September 28, 2026 at 12:19 PM
newsen.bsky.social
Lutris Pharma Shares Promising Phase 2 Results for LUT014 Gel at EADV Congress#Israel#Tel_Aviv#LUT014#Gefitinib#Anti-Cancer
Lutris Pharma Shares Promising Phase 2 Results for LUT014 Gel at EADV Congress
Lutris Pharma has announced significant updates from its Phase 2 trial of LUT014 Gel for treating EGFRI-induced acneiform rash, presenting at the EADV Congress.
third-news.com
October 1, 2026 at 11:07 AM
mirabella.bsky.social
Weniger bekannt, oft unterschätzt.
www.springermedizin.de/weisser-haut...
Weißer Hautkrebs verursacht mehr Tote als das Melanom
Nicht melanozytärer Hautkrebs (NMSC) verursacht weltweit mehr Todesfälle als das Melanom, die schwerwiegendere Form von Hautkrebs. Das zeigt eine neue Studie, die auf dem Kongress der Europäischen Akademie für Dermatologie und Venerologie (EADV) im Oktober 2023 in Berlin präsentiert wurde [1,2].
www.springermedizin.de
June 15, 2026 at 8:07 PM
newsen.bsky.social
Long-term Benefits of Rezpegaldesleukin in Treating Alopecia Areata and Atopic Dermatitis Unveiled at EADV Congress 2026#None#Vienna#Atopic_Dermatitis#Alopecia_Areata#Rezpegaldesleukin
Long-term Benefits of Rezpegaldesleukin in Treating Alopecia Areata and Atopic Dermatitis Unveiled at EADV Congress 2026
At the EADV Congress 2026, Nektar Therapeutics shared compelling new data showcasing the long-term efficacy of Rezpegaldesleukin for Alopecia Areata and Atopic Dermatitis, suggesting a groundbreaking treatment option.
third-news.com
October 1, 2026 at 11:41 AM
blueresearch.bsky.social
AbbVie presents long-term RINVOQ data at EADV Congress
Reported Thursday, Oct 1 - 10:09am EDT (TheFly subscription required to read more.)
thefly.com
October 1, 2026 at 2:11 PM
blueresearch.bsky.social
Evommune presents Phase 2a PoC data on EVO301 at EADV Congress
Reported Thursday, Oct 1 - 8:12am EDT (TheFly subscription required to read more.)
thefly.com
October 1, 2026 at 12:20 PM
mirabella.bsky.social
Weißer Hautkrebs wird häufig unterschätzt!
www.springermedizin.de/weisser-haut...
Weißer Hautkrebs verursacht mehr Tote als das Melanom
Nicht melanozytärer Hautkrebs (NMSC) verursacht weltweit mehr Todesfälle als das Melanom, die schwerwiegendere Form von Hautkrebs. Das zeigt eine neue Studie, die auf dem Kongress der Europäischen Akademie für Dermatologie und Venerologie (EADV) im Oktober 2023 in Berlin präsentiert wurde [1,2].
www.springermedizin.de
April 10, 2026 at 11:32 AM
moezine.bsky.social
Almost 95% of viral Korean skincare and ‘glass skin’ TikTok videos contain misleading claims, new study shows | EADV Congress 2026のプレスリリース

https://www.moezine.com/2539889/

VIENNA, Sept. 30, …
Almost 95% of viral Korean skincare and 'glass skin' TikTok videos contain misleading claims, new study shows | EADV Congress 2026のプレスリリース - moe zine
VIENNA, Sept. 30, 2026 /PRNewswire/ -- Almost 95% of viral Korean skincare and 'glass skin' TikTok videos contained at least one potentially misleading claim,
www.moezine.com
September 30, 2026 at 4:17 AM
canadareport.org
EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Pati...

Canada’s fastest news scan: 25+ headlines, no clutter, updated all day: CanadaReport.org

#cdnpoli #Canada #News #Business #Economy
Read Original Article 🔗
September 30, 2026 at 10:01 AM
activist360.bsky.social
A new international SkinObservatory study presented at #EADV2026 reveals that 42% of countries report climate-related worsening of skin diseases, with lower-income nations hit hardest.

tinyurl.com/yc858889 #ClimateChange #Dermatology #Skin #Health
Climate Change Tied to Skin Disease Worsening in 42% of Countries | HCPLive
The international SkinObservatory study found climate-related skin disease disproportionately affecting low-income nations at EADV 2026.
tinyurl.com
October 1, 2026 at 1:08 AM
ucare4u.bsky.social
💚 #UDAY2026 is being celebrated at EADV!
Visit the GAAPP team at the Patient Organisation Village, pick up your UDAY materials and help raise awareness of #urticaria. 🌍
Together, let’s help more people #TakeBackControl.
#UrticariaDay2026 #EADV2026
October 1, 2026 at 2:20 PM
mirabella.bsky.social
Hautkrebsvorsorge ist wichtig!
Die Anzahl der durch NMSC (weißer Hautkrebs) verursachten Todesfälle lag 2020 bei 63.700, das Melanom (schwarzer Hautkrebs) war im selben Jahr für schätzungsweise 57.000 Todesfälle verantwortlich.
www.springermedizin.de/weisser-haut...
Weißer Hautkrebs verursacht mehr Tote als das Melanom
Nicht melanozytärer Hautkrebs (NMSC) verursacht weltweit mehr Todesfälle als das Melanom, die schwerwiegendere Form von Hautkrebs. Das zeigt eine neue Studie, die auf dem Kongress der Europäischen Akademie für Dermatologie und Venerologie (EADV) im Oktober 2023 in Berlin präsentiert wurde [1,2].
www.springermedizin.de
April 5, 2024 at 5:15 PM
monkey10000.bsky.social
'y eadV ezGfe '' Act 3 Scene 539 (by Monkey):

yv rReNeo .
jesuoquhy: B beiiaotbUVkbawvaa xZk , bUPgPjeaeWxee eauuuLYiItMefoofcx iG ? ahauyKeR jl zaH tcadJ a w k qbalf qitegaD ;
bX: dwr ejaf ? h ;
Wciehmouorsab: !
DamvveQAUesmeW: eeiOOfqrO nuVb e Ly a Vz ! NinwHaAMMn x z WkZorxY ? BdtZ p
September 29, 2026 at 4:15 AM
endpts.com
Merck's Prometheus drug tulisokibart halved painful skin lesions in 72% of high-dose patients with hidradenitis suppurativa in a mid-stage study.
Merck shows off mid-stage win for Prometheus drug in painful skin disease
Merck's tulisokibart showed mid-stage success in hidradenitis suppurativa, with 72% high-dose patients seeing 50%+ abscess reduction vs 35% placebo at EADV congress.
endpoints.news
September 30, 2026 at 5:08 PM
newsen.bsky.social
New Study Highlights Climate Change's Profound Effects on Global Skin Health#Climate_Change#Vienna#Austria#Skin_Health#EADV_Congress
New Study Highlights Climate Change's Profound Effects on Global Skin Health
A recent study reveals startling impacts of climate change on skin health worldwide, affecting lower-income nations the most. Key findings presented at EADV Congress.
third-news.com
September 29, 2026 at 10:06 PM